Sanuwave Health vs Trisalus Life Sciences
Sanuwave Health and Trisalus Life Sciences are similar in size: $44.1m and $45.2m of revenue in their latest fiscal years. Trisalus Life Sciences grew faster (53.4% against 35.0%). Sanuwave Health kept more of each dollar of sales as profit: a net margin of 26.8% against -86.9%.
| Latest fiscal year | Sanuwave HealthSNWV, 2025 | Trisalus Life SciencesTLSI, 2025 |
|---|---|---|
| Revenue | $44.1m | $45.2m |
| Revenue growth | 35.0% | 53.4% |
| Net income | $11.8m | −$39.2m |
| Operating margin | 11.2% | -59.7% |
| Net margin | 26.8% | -86.9% |
| Return on equity | — | — |
| Free cash flow | $1.9m | −$18.9m |
| Cash | $12.0m | $20.4m |
| Total debt | $22.2m | $33.0m |
| Debt to equity | 1372.3% | — |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 55 | 102 |
| Market value | $51.4m | $213m |
| Price vs our value range | — | — |
| Moat score | 33 (Weak) | — |
| Insider trades, 12 months | 0 buys, 21 sales | 12 buys, 18 sales |